← Eichor
Condition: Cancer Therapy Related Cardiac Dysfunction Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Cancer Therapy Related Cardiac Dysfunction

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)
Phase 4 · 4 location(s) · Silesian Centre for Heart Diseases · NCT05465031Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients
Phase 2 · 1 location(s) · University Hospital, Akershus · NCT05732051ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies
Phase N/A · 1 location(s) · University Hospital, Caen · NCT07191730Treating Heart Dysfunction Related to Cancer Therapy With Sacubitril/Valsartan
Phase 1/Phase 2 · 1 location(s) · Virginia Commonwealth University · NCT05194111The STOP-MED CTRCD Trial
Phase 4 · 14 location(s) · Dinesh Thavendiranathan · NCT06183437Cardiovascular Multimodality Imaging Study
Phase N/A · 1 location(s) · Montefiore Medical Center · NCT06610019
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.